"drug license agreement" - Google News

Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI - Pharmaceutical Executive

Fri, 05 Jun 2026 13:54:22 GMT

Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI Pharmaceutical Executive

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI - Business Wire

Thu, 04 Jun 2026 07:00:00 GMT

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI Business Wire

Pfizer signs licence agreement with Chai for AI drug discovery - Pharmaceutical Technology

Fri, 05 Jun 2026 09:47:54 GMT

Pfizer signs licence agreement with Chai for AI drug discovery Pharmaceutical Technology

Gan & Lee Pharmaceuticals Signs Exclusive License Agreement with JW Pharmaceutical, the Leading South Korean Pharma, to Advance the Global Commercialization of the Innovative GLP-1 Receptor Agonist Bofanglutide - PR Newswire

Thu, 09 Apr 2026 07:00:00 GMT

Gan & Lee Pharmaceuticals Signs Exclusive License Agreement with JW Pharmaceutical, the Leading South Korean Pharma, to Advance the Global Commercialization of the Innovative GLP-1 Receptor Agonist Bofanglutide PR Newswire

Latham & Watkins Advises Chugai Pharmaceutical in US$1.085 Billion License Agreement With Rani Therapeutics - Latham & Watkins LLP

Wed, 22 Oct 2025 07:00:00 GMT

Latham & Watkins Advises Chugai Pharmaceutical in US$1.085 Billion License Agreement With Rani Therapeutics Latham & Watkins LLP

Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea - Ocugen, Inc.

Mon, 15 Sep 2025 07:00:00 GMT

Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea Ocugen, Inc.

Travere pays $112.5M to pursue new pill for rare kidney diseases - Stock Titan

Tue, 02 Jun 2026 07:00:00 GMT

Travere pays $112.5M to pursue new pill for rare kidney diseases Stock Titan

Haisco Enters $745 Million Exclusive License Agreement with AbbVie - Pharmaceutical Executive

Tue, 14 Apr 2026 07:00:00 GMT

Haisco Enters $745 Million Exclusive License Agreement with AbbVie Pharmaceutical Executive

Halozyme Announces Global Collaboration and License Agreement with Vertex Pharmaceuticals for Hypercon™ Technology - PR Newswire

Tue, 07 Apr 2026 07:00:00 GMT

Halozyme Announces Global Collaboration and License Agreement with Vertex Pharmaceuticals for Hypercon™ Technology PR Newswire

Formosa and Rxilient sign licensing agreement for APP13007 - Pharmaceutical Technology

Thu, 04 Dec 2025 08:00:00 GMT

Formosa and Rxilient sign licensing agreement for APP13007 Pharmaceutical Technology

Rare blood disorder drug deal gives Agios shot at $1B U.S. sales - Stock Titan

Mon, 01 Jun 2026 09:00:00 GMT

Rare blood disorder drug deal gives Agios shot at $1B U.S. sales Stock Titan

Eli Lilly and Insilico Enter $2.75 Billion Research and Licensing Agreement to Advance AI Drug Discovery - Pharmaceutical Executive

Mon, 30 Mar 2026 07:00:00 GMT

Eli Lilly and Insilico Enter $2.75 Billion Research and Licensing Agreement to Advance AI Drug Discovery Pharmaceutical Executive

Halozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-Formulated with ENHANZE® for Obesity - PR Newswire

Mon, 05 Jan 2026 08:00:00 GMT

Halozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-Formulated with ENHANZE® for Obesity PR Newswire

AbbVie and Haisco Enter $745 Million Licensing Agreement | PharmExec - Pharmaceutical Executive

Tue, 14 Apr 2026 07:00:00 GMT

AbbVie and Haisco Enter $745 Million Licensing Agreement | PharmExec Pharmaceutical Executive

Halozyme Announces Global Collaboration and License Agreement with Takeda to Develop and Commercialize Vedolizumab with ENHANZE® - PR Newswire

Thu, 08 Jan 2026 08:00:00 GMT

Halozyme Announces Global Collaboration and License Agreement with Takeda to Develop and Commercialize Vedolizumab with ENHANZE® PR Newswire

AstraZeneca Reaches $2 Billion License Agreement with Jacobio Pharma for Pan-KRAS Inhibitor - Pharmaceutical Executive

Mon, 22 Dec 2025 08:00:00 GMT

AstraZeneca Reaches $2 Billion License Agreement with Jacobio Pharma for Pan-KRAS Inhibitor Pharmaceutical Executive

Merus and Halozyme Enter Global Collaboration and License Agreement to Develop Subcutaneous Formulation of Petosemtamab - PR Newswire

Mon, 17 Nov 2025 08:00:00 GMT

Merus and Halozyme Enter Global Collaboration and License Agreement to Develop Subcutaneous Formulation of Petosemtamab PR Newswire

Mergers and Acquisitions Roundup: GSK and Alfasigma Enter Licensing Agreement for Linerixibat, Servier Enters $2.5 Billion Definitive Agreement to Acquire Day One Pharmaceuticals - Pharmaceutical Executive

Mon, 09 Mar 2026 07:00:00 GMT

Mergers and Acquisitions Roundup: GSK and Alfasigma Enter Licensing Agreement for Linerixibat, Servier Enters $2.5 Billion Definitive Agreement to Acquire Day One Pharmaceuticals Pharmaceutical Executive

Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon™ Technology - PR Newswire

Wed, 06 May 2026 07:00:00 GMT

Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon™ Technology PR Newswire

Nimbus Therapeutics and Eli Lilly Enter $1.3 Billion License Agreement and Research Collaboration for Oral Obesity Treatments - Pharmaceutical Executive

Tue, 06 Jan 2026 08:00:00 GMT

Nimbus Therapeutics and Eli Lilly Enter $1.3 Billion License Agreement and Research Collaboration for Oral Obesity Treatments Pharmaceutical Executive

Boehringer Ingelheim Enters $1.26 Billion Collaboration and License Agreement with Simcere Pharmaceuticals to Develop Pre-Clinical Bispecific Antibody - Pharmaceutical Executive

Tue, 27 Jan 2026 08:00:00 GMT

Boehringer Ingelheim Enters $1.26 Billion Collaboration and License Agreement with Simcere Pharmaceuticals to Develop Pre-Clinical Bispecific Antibody Pharmaceutical Executive

Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide - Yahoo Finance

Tue, 27 Jan 2026 08:00:00 GMT

Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide Yahoo Finance

Chai Discovery Announces License Agreement With Pfizer To Accelerate Drug Discovery With AI - TradingView

Thu, 04 Jun 2026 14:51:50 GMT

Chai Discovery Announces License Agreement With Pfizer To Accelerate Drug Discovery With AI TradingView

Halozyme Announces Global Collaboration and License Agreement with GSK to Develop Subcutaneous Formulations of Multiple Promising Oncology Targets - PR Newswire

Thu, 07 May 2026 07:00:00 GMT

Halozyme Announces Global Collaboration and License Agreement with GSK to Develop Subcutaneous Formulations of Multiple Promising Oncology Targets PR Newswire

Royalties In Hybrid Licensing Agreements: Careful Drafting Is Critical - Life Science Leader

Mon, 27 Oct 2025 07:00:00 GMT

Royalties In Hybrid Licensing Agreements: Careful Drafting Is Critical Life Science Leader

SanegeneBio Enters $1.5 Billion Exclusive Global License Agreement with Genentech for RNAi Program - Pharmaceutical Executive

Tue, 03 Feb 2026 08:00:00 GMT

SanegeneBio Enters $1.5 Billion Exclusive Global License Agreement with Genentech for RNAi Program Pharmaceutical Executive

Novartis enters licensing agreement with UNP for peptide therapeutics - Pharmaceutical Technology

Thu, 19 Feb 2026 08:00:00 GMT

Novartis enters licensing agreement with UNP for peptide therapeutics Pharmaceutical Technology

Pfizer Enters Exclusive Collaboration and License Agreement with Yao Pharma for Oral Small-Molecule GLP-1 Agonists - Pharmaceutical Executive

Tue, 09 Dec 2025 08:00:00 GMT

Pfizer Enters Exclusive Collaboration and License Agreement with Yao Pharma for Oral Small-Molecule GLP-1 Agonists Pharmaceutical Executive

BenchSci signs license agreement with Sanofi for drug development platform - MobiHealthNews

Thu, 09 Oct 2025 07:00:00 GMT

BenchSci signs license agreement with Sanofi for drug development platform MobiHealthNews

Asahi Kasei Pharma Strengthens Preclinical Pipeline Through Exclusive Global License Agreement with Alchemedicine for Novel Lead Compounds - Business Wire

Wed, 25 Feb 2026 08:00:00 GMT

Asahi Kasei Pharma Strengthens Preclinical Pipeline Through Exclusive Global License Agreement with Alchemedicine for Novel Lead Compounds Business Wire

Alloy Therapeutics Enters into Multi-Target Collaboration and License Agreement with Biogen for Use of Alloy’s AntiClastic™ ASO Platform - Business Wire

Tue, 07 Apr 2026 07:00:00 GMT

Alloy Therapeutics Enters into Multi-Target Collaboration and License Agreement with Biogen for Use of Alloy’s AntiClastic™ ASO Platform Business Wire

Halozyme, Vertex Pharmaceuticals Enter Exclusive Collab & License Agreement - Contract Pharma

Tue, 07 Apr 2026 07:00:00 GMT

Halozyme, Vertex Pharmaceuticals Enter Exclusive Collab & License Agreement Contract Pharma

THX Pharma and Biocodex sign licensing deal for Batten-1 and TX01 drugs - Pharmaceutical Technology

Wed, 11 Feb 2026 08:00:00 GMT

THX Pharma and Biocodex sign licensing deal for Batten-1 and TX01 drugs Pharmaceutical Technology

THX Pharma and Biocodex Enter Licensing Agreemnt to Advance Two Drug Candidates Across Multiple Rare Diseases - Pharmaceutical Executive

Wed, 11 Feb 2026 08:00:00 GMT

THX Pharma and Biocodex Enter Licensing Agreemnt to Advance Two Drug Candidates Across Multiple Rare Diseases Pharmaceutical Executive

GSK backs siRNA modality through $1bn Frontier deal - Pharmaceutical Technology

Tue, 24 Feb 2026 08:00:00 GMT

GSK backs siRNA modality through $1bn Frontier deal Pharmaceutical Technology

Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma - Business Wire

Tue, 09 Dec 2025 08:00:00 GMT

Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma Business Wire

Latham Advises Norgine on Exclusive Licensing Agreement With Vir Biotechnology - Latham & Watkins LLP

Wed, 17 Dec 2025 08:00:00 GMT

Latham Advises Norgine on Exclusive Licensing Agreement With Vir Biotechnology Latham & Watkins LLP

Insilico Medicine and Taigen achieves license agreement to develop and commercialize AI-driven PHD inhibitor for anemia of Chronic Kidney Disease (CKD) - Insilico Medicine

Thu, 11 Dec 2025 08:00:00 GMT

Insilico Medicine and Taigen achieves license agreement to develop and commercialize AI-driven PHD inhibitor for anemia of Chronic Kidney Disease (CKD) Insilico Medicine

Novartis and Monte Rosa Therapeutics Announce $5.7 Billion Licensing Agreement Deal for Protein Degraders - Pharmaceutical Executive

Mon, 15 Sep 2025 07:00:00 GMT

Novartis and Monte Rosa Therapeutics Announce $5.7 Billion Licensing Agreement Deal for Protein Degraders Pharmaceutical Executive

AbbVie strikes up to $745M pain-drug deal with China's Haisco - Stock Titan

Sun, 12 Apr 2026 07:00:00 GMT

AbbVie strikes up to $745M pain-drug deal with China's Haisco Stock Titan

THX Pharma and Biocodex Announce a Strategic Licensing Agreement in Batten, Gaucher and Niemann-Pick Type C Diseases - Business Wire

Tue, 10 Feb 2026 08:00:00 GMT

THX Pharma and Biocodex Announce a Strategic Licensing Agreement in Batten, Gaucher and Niemann-Pick Type C Diseases Business Wire

JPM26: AbbVie and RemeGen kick off deals with $5.6bn oncology agreement - Pharmaceutical Technology

Mon, 12 Jan 2026 08:00:00 GMT

JPM26: AbbVie and RemeGen kick off deals with $5.6bn oncology agreement Pharmaceutical Technology

Janux Therapeutics Enters $850 Million Collaboration and Exclusive License Agreement with Bristol Myers Squibb to Develop Tumor-Activated Therapeutics - Pharmaceutical Executive

Thu, 22 Jan 2026 08:00:00 GMT

Janux Therapeutics Enters $850 Million Collaboration and Exclusive License Agreement with Bristol Myers Squibb to Develop Tumor-Activated Therapeutics Pharmaceutical Executive

RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries - PR Newswire

Mon, 18 Aug 2025 07:00:00 GMT

RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries PR Newswire

Skye Bioscience Licenses Halozyme’s ENHANZE Drug Delivery Technology - Contract Pharma

Mon, 05 Jan 2026 08:00:00 GMT

Skye Bioscience Licenses Halozyme’s ENHANZE Drug Delivery Technology Contract Pharma

Ventus Therapeutics Enters into a Collaboration and License Agreement with Genentech to Discover and Develop Small-Molecule Medicines Using Ventus’ ReSOLVE® Platform - Ventus Therapeutics

Tue, 21 Oct 2025 07:00:00 GMT

Ventus Therapeutics Enters into a Collaboration and License Agreement with Genentech to Discover and Develop Small-Molecule Medicines Using Ventus’ ReSOLVE® Platform Ventus Therapeutics

Ocugen and Kwangdong complete licensing agreement for OCU400 gene therapy in Korea - Ophthalmology Times

Mon, 15 Sep 2025 07:00:00 GMT

Ocugen and Kwangdong complete licensing agreement for OCU400 gene therapy in Korea Ophthalmology Times

Samsung Bioepis and Epis NexLab Sign Research Collaboration and License Agreement with G2GBIO to Develop Novel Assets Including Long-acting Semaglutide - Business Wire

Sun, 15 Mar 2026 07:00:00 GMT

Samsung Bioepis and Epis NexLab Sign Research Collaboration and License Agreement with G2GBIO to Develop Novel Assets Including Long-acting Semaglutide Business Wire

Cancer drug rights shift: Lisata takes back certepetide in China - Stock Titan

Tue, 27 Jan 2026 08:00:00 GMT

Cancer drug rights shift: Lisata takes back certepetide in China Stock Titan

Zonsen PepLib Biotech Enters Global R&D Collaboration and License Agreement with Lilly - Business Wire

Tue, 03 Feb 2026 08:00:00 GMT

Zonsen PepLib Biotech Enters Global R&D Collaboration and License Agreement with Lilly Business Wire

DISCO Pharmaceuticals Enters License Agreement to Advance Novel Cancer Surfaceome Targeted Therapies - GlobeNewswire

Wed, 07 Jan 2026 08:00:00 GMT

DISCO Pharmaceuticals Enters License Agreement to Advance Novel Cancer Surfaceome Targeted Therapies GlobeNewswire

MediLink and Roche announce exclusive licensing agreement for YL201 - Pharmaceutical Technology

Mon, 12 Jan 2026 08:00:00 GMT

MediLink and Roche announce exclusive licensing agreement for YL201 Pharmaceutical Technology

Nimbus Therapeutics Announces Research Collaboration and License Agreement with Lilly for Novel Oral Obesity Treatment - Business Wire

Tue, 06 Jan 2026 08:00:00 GMT

Nimbus Therapeutics Announces Research Collaboration and License Agreement with Lilly for Novel Oral Obesity Treatment Business Wire

Novartis signs two major deals at JPM conference - BioXconomy

Wed, 14 Jan 2026 08:00:00 GMT

Novartis signs two major deals at JPM conference BioXconomy

Starpharma Announces a Collaboration and License Agreement with Genentech - GlobeNewswire

Mon, 22 Sep 2025 07:00:00 GMT

Starpharma Announces a Collaboration and License Agreement with Genentech GlobeNewswire

Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide - GlobeNewswire

Tue, 27 Jan 2026 08:00:00 GMT

Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide GlobeNewswire

Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million - The Providence Journal

Mon, 12 Jan 2026 08:00:00 GMT

Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million The Providence Journal

Halozyme inks license agreement with Vertex - The Pharma Letter

Wed, 08 Apr 2026 07:00:00 GMT

Halozyme inks license agreement with Vertex The Pharma Letter

Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China - GlobeNewswire

Mon, 29 Dec 2025 08:00:00 GMT

Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China GlobeNewswire

Swiss-Japanese ADC player Araris expands Chugai pact with $780m licensing agreement - European Biotechnology Magazine

Wed, 11 Feb 2026 08:00:00 GMT

Swiss-Japanese ADC player Araris expands Chugai pact with $780m licensing agreement European Biotechnology Magazine

GSK Licenses Halozyme ENHANZE for Subcutaneous Cancer Drugs - Contract Pharma

Thu, 07 May 2026 07:00:00 GMT

GSK Licenses Halozyme ENHANZE for Subcutaneous Cancer Drugs Contract Pharma

Madrigal expands MASH pipeline in $4.4bn siRNA licensing deal - Pharmaceutical Technology

Thu, 12 Feb 2026 08:00:00 GMT

Madrigal expands MASH pipeline in $4.4bn siRNA licensing deal Pharmaceutical Technology

Servier Enters $450 million Definitive License Agreement with Kaerus Bioscience for KER-0193 - Pharmaceutical Executive

Mon, 08 Sep 2025 07:00:00 GMT

Servier Enters $450 million Definitive License Agreement with Kaerus Bioscience for KER-0193 Pharmaceutical Executive

ADEL Signs $1.04 Billion Global License Agreement with Sanofi for ADEL-Y01, a Novel investigational Alzheimer's Disease Therapy - PR Newswire

Mon, 15 Dec 2025 08:00:00 GMT

ADEL Signs $1.04 Billion Global License Agreement with Sanofi for ADEL-Y01, a Novel investigational Alzheimer's Disease Therapy PR Newswire

NorthStrive Biosciences Signs Definitive License Agreement for Commercialization of EL-22 and EL-32, a Myostatin-Engineered Probiotic for Muscle Preservation in Animal Health - Yahoo Finance

Wed, 11 Feb 2026 08:00:00 GMT

NorthStrive Biosciences Signs Definitive License Agreement for Commercialization of EL-22 and EL-32, a Myostatin-Engineered Probiotic for Muscle Preservation in Animal Health Yahoo Finance

4DMT Announces Exclusive License Agreement with Otsuka - GlobeNewswire

Thu, 30 Oct 2025 07:00:00 GMT

4DMT Announces Exclusive License Agreement with Otsuka GlobeNewswire

Ripple & Bausch’s licensing agreement: What it means in ocular delivery - News-Medical

Fri, 05 Dec 2025 08:00:00 GMT

Ripple & Bausch’s licensing agreement: What it means in ocular delivery News-Medical

GSK, AnaptysBio Sue Each Other Over Cancer Drug License - WSJ

Fri, 21 Nov 2025 08:00:00 GMT

GSK, AnaptysBio Sue Each Other Over Cancer Drug License WSJ

Chinese biotechs strike a record US$136 billion in out-licensing deals in 2025 - South China Morning Post

Thu, 08 Jan 2026 08:00:00 GMT

Chinese biotechs strike a record US$136 billion in out-licensing deals in 2025 South China Morning Post

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound - ACCESS Newswire

Mon, 12 Jan 2026 08:00:00 GMT

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound ACCESS Newswire

BenchSci Announces Three-Year License Agreement with Sanofi to Access and Use BenchSci’s ASCEND Platform - Business Wire

Wed, 08 Oct 2025 07:00:00 GMT

BenchSci Announces Three-Year License Agreement with Sanofi to Access and Use BenchSci’s ASCEND Platform Business Wire

WilmerHale Advises Gate Bioscience on $856M Collaboration and License Agreement with Lilly - WilmerHale

Mon, 28 Jul 2025 07:00:00 GMT

WilmerHale Advises Gate Bioscience on $856M Collaboration and License Agreement with Lilly WilmerHale

Novo Nordisk and Omeros announce asset purchase and license - GlobeNewswire

Wed, 15 Oct 2025 07:00:00 GMT

Novo Nordisk and Omeros announce asset purchase and license GlobeNewswire

GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate - Pharmaceutical Executive

Mon, 27 Oct 2025 07:00:00 GMT

GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate Pharmaceutical Executive

Licensing galore: Roche ties up with Hansoh on ADCs as Rani rounds out week with Chugai pact - Fierce Biotech

Fri, 17 Oct 2025 07:00:00 GMT

Licensing galore: Roche ties up with Hansoh on ADCs as Rani rounds out week with Chugai pact Fierce Biotech

Angelini Pharma and Quiver Bioscience Announce Strategic Research Collaboration and Licensing Agreement to Discover and Advance Novel Therapeutics for Genetic Epilepsies - Business Wire

Mon, 23 Feb 2026 08:00:00 GMT

Angelini Pharma and Quiver Bioscience Announce Strategic Research Collaboration and Licensing Agreement to Discover and Advance Novel Therapeutics for Genetic Epilepsies Business Wire

Datavault AI Inc. Announces a $10M Worldwide Exclusive License Agreement with Scilex Holding Company for Tokenization and Monetization of Real-World Assets (RWA) in Genomic, DNA Data, Diagnostics, Therapeutics, Genetic, and Drug Information - Yahoo Finance

Tue, 04 Nov 2025 08:00:00 GMT

Datavault AI Inc. Announces a $10M Worldwide Exclusive License Agreement with Scilex Holding Company for Tokenization and Monetization of Real-World Assets (RWA) in Genomic, DNA Data, Diagnostics, Therapeutics, Genetic, and Drug Information Yahoo Finance

SFI Health™ EMEA Announces Exclusive License Agreement with Curasense BV for Equazen - Business Wire

Thu, 25 Sep 2025 07:00:00 GMT

SFI Health™ EMEA Announces Exclusive License Agreement with Curasense BV for Equazen Business Wire

Vertex taps Halozyme tech to shrink injections for at-home use - Stock Titan

Tue, 07 Apr 2026 07:00:00 GMT

Vertex taps Halozyme tech to shrink injections for at-home use Stock Titan

Health Hope Pharma Enters into Exclusive Licensing Agreement with Gilead Sciences - PR Newswire

Mon, 29 Sep 2025 07:00:00 GMT

Health Hope Pharma Enters into Exclusive Licensing Agreement with Gilead Sciences PR Newswire

Ventus Therapeutics Enters into a Collaboration and License Agreement with Genentech to Discover and Develop Small-Molecule Medicines Using Ventus' ReSOLVE® Platform - Business Wire

Tue, 21 Oct 2025 07:00:00 GMT

Ventus Therapeutics Enters into a Collaboration and License Agreement with Genentech to Discover and Develop Small-Molecule Medicines Using Ventus' ReSOLVE® Platform Business Wire

Jazz Pharmaceuticals & Saniona Enter an Exclusive Licensing Agreement to Develop and Commercialize SAN2355 - Pharmaceutical Executive

Wed, 20 Aug 2025 07:00:00 GMT

Jazz Pharmaceuticals & Saniona Enter an Exclusive Licensing Agreement to Develop and Commercialize SAN2355 Pharmaceutical Executive

Fierce Pharma Asia—Licensing deal flow, China crackdown warning and ESMO readouts - Fierce Pharma

Fri, 24 Oct 2025 07:00:00 GMT

Fierce Pharma Asia—Licensing deal flow, China crackdown warning and ESMO readouts Fierce Pharma

Madrigal Pharmaceuticals and CSPC Pharmaceutical Group Limited Enter Exclusive Global License Agreement for GLP-1 Receptor Agonist SYH2086 - Pharmaceutical Executive

Wed, 30 Jul 2025 07:00:00 GMT

Madrigal Pharmaceuticals and CSPC Pharmaceutical Group Limited Enter Exclusive Global License Agreement for GLP-1 Receptor Agonist SYH2086 Pharmaceutical Executive

Teva and Prestige Biopharma enter license agreement for Tuznue commercialization in Europe - Select Science

Mon, 03 Nov 2025 06:27:30 GMT

Teva and Prestige Biopharma enter license agreement for Tuznue commercialization in Europe Select Science

Glenmark Specialty Enters $1 Billion Exclusive License Agreement with Hengrui for Trastuzumab Rezetecan - Pharmaceutical Executive

Wed, 24 Sep 2025 07:00:00 GMT

Glenmark Specialty Enters $1 Billion Exclusive License Agreement with Hengrui for Trastuzumab Rezetecan Pharmaceutical Executive

Drugs from China are reshaping biotech. Track the licensing deals here. - BioPharma Dive

Mon, 25 Aug 2025 07:00:00 GMT

Drugs from China are reshaping biotech. Track the licensing deals here. BioPharma Dive

GSK taps Halozyme to pursue easier cancer drug injections - Stock Titan

Thu, 07 May 2026 07:00:00 GMT

GSK taps Halozyme to pursue easier cancer drug injections Stock Titan

Eisai strikes Japan licensing deal with Shanghai Henlius Biotech - Reuters

Thu, 05 Feb 2026 08:00:00 GMT

Eisai strikes Japan licensing deal with Shanghai Henlius Biotech Reuters

Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan - Business Wire

Wed, 11 Mar 2026 07:00:00 GMT

Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan Business Wire

Biotech firms eye licensing changes to curb Trump’s MFN drug pricing impact - medwatch.com

Wed, 18 Mar 2026 07:00:00 GMT

Biotech firms eye licensing changes to curb Trump’s MFN drug pricing impact medwatch.com

Isofol secures license for arfolitixorin in autism - Biostock

Thu, 19 Mar 2026 07:00:00 GMT

Isofol secures license for arfolitixorin in autism Biostock

Lupin, Valorum ink licensing agreement for Armlupeg biosimilar - Drug Store News

Thu, 11 Dec 2025 08:00:00 GMT

Lupin, Valorum ink licensing agreement for Armlupeg biosimilar Drug Store News

Sino Biopharm Licenses Blood Cancer Drug to Sanofi in $1.53B Deal - Global Banking & Finance Review

Tue, 03 Mar 2026 08:00:00 GMT

Sino Biopharm Licenses Blood Cancer Drug to Sanofi in $1.53B Deal Global Banking & Finance Review

Revlon announces global fragrance licensing agreement with Champion - Drug Store News

Wed, 12 Nov 2025 08:00:00 GMT

Revlon announces global fragrance licensing agreement with Champion Drug Store News

MEDIPOST Announces the Exclusive Commercialization License Agreement with Teikoku Seiyaku for Knee Osteoarthritis Treatment CARTISTEM® in Japan - BioSpace

Fri, 19 Dec 2025 08:00:00 GMT

MEDIPOST Announces the Exclusive Commercialization License Agreement with Teikoku Seiyaku for Knee Osteoarthritis Treatment CARTISTEM® in Japan BioSpace

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano - Business Wire

Mon, 30 Mar 2026 07:00:00 GMT

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano Business Wire

Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan - Business Wire

Mon, 12 Jan 2026 08:00:00 GMT

Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan Business Wire

Biocerta Precision Diagnostics Announces Exclusive Licensing Agreement With the University of Miami and Strategic Development Partnership With Acumen Partners - Business Wire

Wed, 17 Dec 2025 08:00:00 GMT

Biocerta Precision Diagnostics Announces Exclusive Licensing Agreement With the University of Miami and Strategic Development Partnership With Acumen Partners Business Wire

PMGC Holdings (NASDAQ: ELAB) revises MOA license milestones and timelines - Stock Titan

Fri, 27 Mar 2026 07:00:00 GMT

PMGC Holdings (NASDAQ: ELAB) revises MOA license milestones and timelines Stock Titan